Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
268 studies found for:    Open Studies | "Carcinoma, Renal Cell"
Show Display Options
Rank Status Study
21 Recruiting Stereotactic Body Radiation Therapy and T-Cell Infusion in Treating Patients With Metastatic Kidney Cancer
Conditions: Clear Cell Renal Cell Carcinoma;   Recurrent Renal Cell Cancer;   Stage IV Renal Cell Cancer
Interventions: Radiation: stereotactic body radiation therapy;   Drug: cyclophosphamide;   Biological: therapeutic autologous lymphocytes;   Other: laboratory biomarker analysis
22 Recruiting Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer
Conditions: Estrogen Receptor-positive Breast Cancer;   Gastrinoma;   Glucagonoma;   HER2-negative Breast Cancer;   Insulinoma;   Mucositis;   Oral Complications;   Pancreatic Polypeptide Tumor;   Progesterone Receptor-positive Breast Cancer;   Recurrent Breast Cancer;   Recurrent Islet Cell Carcinoma;   Recurrent Renal Cell Cancer;   Somatostatinoma;   Stage III Renal Cell Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer;   Stage IV Renal Cell Cancer
Intervention: Drug: everolimus
23 Recruiting Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer
Conditions: Clear Cell Renal Cell Carcinoma;   Stage III Renal Cell Cancer;   Stage IV Renal Cell Cancer
Interventions: Drug: Cabozantinib S-malate;   Drug: Sunitinib Malate;   Other: Laboratory Biomarker Analysis
24 Recruiting Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer
Conditions: Recurrent Renal Cell Carcinoma;   Stage III Renal Cell Cancer;   Stage IV Renal Cell Cancer
Interventions: Biological: Trebananib;   Biological: Bevacizumab;   Drug: Pazopanib Hydrochloride;   Drug: Sorafenib Tosylate;   Drug: Sunitinib Malate;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
25 Recruiting Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
Conditions: Clear Cell Renal Cell Carcinoma;   Recurrent Renal Cell Carcinoma;   Stage IV Renal Cell Cancer
Interventions: Drug: Pazopanib Hydrochloride;   Other: Placebo;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Other: Pharmacological Study
26 Recruiting S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Condition: Kidney Cancer
Interventions: Drug: everolimus;   Other: placebo
27 Recruiting Adjuvant Axitinib Therapy of Renal Cell Cancer in High Risk Patients
Condition: Clear Cell Renal Carcinoma
Interventions: Drug: Axitinib;   Drug: Placebo
28 Recruiting Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
Conditions: Renal Tumor Histology;   Cutaneous Leiomyomatosis;   Kidney Cancer
Intervention:
29 Unknown  Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Interventions: Biological: therapeutic allogeneic lymphocytes;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Procedure: allogeneic bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation
30 Recruiting Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer
Condition: Metastatic Renal Cell Cancer
Interventions: Drug: RX-0201;   Drug: Everolimus
31 Unknown  Novel Prognostic Markers in Renal Cancer
Condition: Renal Cell Carcinoma
Intervention:
32 Unknown  Ultrasound in Assessing Antiangiogenic Treatment in Patients With Advanced Kidney Cancer
Conditions: Kidney Cancer;   Metastatic Cancer
Interventions: Drug: antiangiogenesis therapy;   Drug: stabilized sulphur hexafluoride microbubble-based contrast agent;   Other: imaging biomarker analysis;   Other: pharmacological study;   Procedure: computed tomography;   Procedure: magnetic resonance imaging
33 Unknown  Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer
Condition: Kidney Cancer
Intervention: Drug: sunitinib malate
34 Not yet recruiting REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT
Conditions: Renal Cell Carcinoma;   Kidney Cancer
Intervention: Drug: Iodine (124I) Girentuximab
35 Recruiting Optical Biopsy to Improve the Diagnosis of Kidney Cancer
Condition: Kidney Cancer
Intervention: Device: Percutaneous Optical Biopsy (OCT and DRS)
36 Recruiting Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Kidney Cancer Undergoing Surgery
Conditions: Recurrent Renal Cell Cancer;   Stage IV Renal Cell Cancer
Interventions: Radiation: stereotactic body radiation therapy;   Procedure: therapeutic conventional surgery;   Other: laboratory biomarker analysis
37 Recruiting Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)
Condition: Kidney Cancer
Interventions: Drug: Pazopanib;   Drug: Temsirolimus;   Behavioral: Quality of Life Assessment;   Drug: Benadryl
38 Recruiting A Prospective Pilot Study Evaluating Renal Lesions Through Contrast-enhanced Ultrasound (US) in Patients With Renal Cancer and in Those With a Risk Factor for Renal Malignancy
Condition: Kidney Cancer
Interventions: Procedure: Contrast-enhanced Ultrasound;   Drug: Perflutren lipid
39 Recruiting Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC)
Conditions: Genitourinary Cancer;   Kidney Cancer
Interventions: Drug: Sunitinib;   Behavioral: Questionnaire
40 Recruiting Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
Conditions: Kidney Neoplasms;   Kidney Cancer;   Pneumothorax;   FLCN Protien, Human
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years